# Screening for Atrial Fibrillation in Pulmonary Embolism Study -SAFE-PE Study

> **NCT03274401** · NA · TERMINATED · sponsor: **Danderyd Hospital** · enrollment: 90 (actual)

## Conditions studied

- Atrial Fibrillation
- Pulmonary Embolism

## Interventions

- **DEVICE:** Zenicor intermittent ECG device
- **DEVICE:** 5 day ECG patch

## Key facts

- **NCT ID:** NCT03274401
- **Lead sponsor:** Danderyd Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-09-13
- **Primary completion:** 2020-12-31
- **Final completion:** 2022-04-01
- **Target enrollment:** 90 (ACTUAL)
- **Why stopped:** Due to Covid-19
- **Last updated:** 2022-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03274401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03274401, "Screening for Atrial Fibrillation in Pulmonary Embolism Study -SAFE-PE Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03274401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*